Penn Vet Researchers Reveal Hidden Architecture of the Retina’s First Synapse

For photoreceptors, the cells in the retina that capture light and initiate vision, the most important conversations with other cells happen at structures so small they have long resisted clear view. Now, vision scientists from the Division of Experimental Retinal Therapies (ExpeRTs) at the University of Pennsylvania School of Veterinary Medicine (Penn Vet) have found a way to see those structures in far greater detail.

In a new study published in the journal Investigative Ophthalmology & Visual Science, the Penn Vet team used a powerful imaging approach called ultrastructure expansion microscopy, or U-ExM, to examine photoreceptor ribbon synapses, the specialized junctions where light-sensing cells pass visual information deeper into the retina. By physically expanding preserved retinal tissue and labeling its proteins, the researchers were able to map these nanoscale structures in ways that standard imaging methods often cannot, especially in archival samples chemically fixed and stored for long periods.

Ribbon synapses are essential to vision. They allow photoreceptors to continuously release neurotransmitters and relay visual signals across changing light conditions. But they are also extraordinarily complex, with tightly packed cellular components that are difficult to resolve with conventional light microscopy. Electron microscopy has offered important structural snapshots, but it is labor-intensive and less practical for broad molecular mapping. The investigators’ approach provides a new way to study these synapses with both molecular specificity and great spatial detail.

Revealing the Molecular Architecture of Photoreceptor Synapses

Using retinal tissue from dogs, an important large-animal model in vision research, the researchers tested 44 antibodies targeting 29 ribbon synapse-associated proteins. In standard immunostaining of fixed frozen tissue, many performed poorly, a common problem when fixation masks the protein features that antibodies need to recognize. With U-ExM, compatibility rose to about 80%, allowing the team to reliably visualize 35 of the 44 antibodies tested. In other words, the method did not just sharpen the image; it made far more of the tissue biologically interpretable.

That improved view opened the door to a much more detailed understanding of how photoreceptor synapses are built. Using U-ExM to map proteins within these tiny structures, the Penn Vet team was able to resolve molecular arrangements that were difficult to distinguish with conventional imaging and uncover structural features that had previously been hard to see in preserved retinal tissue. The method also enabled comparison of these nanoscale architectures across different photoreceptor types and stages of retinal maturation, offering a new framework for studying how the retina’s synaptic circuitry is organized in health and how it may change in disease.

“The retina’s first synapse is incredibly small and densely organized, which makes it difficult to study with conventional tools,” said Kei Takahashi, a post-doctoral fellow in the Beltran lab, and first author of the paper. “By combining tissue expansion with molecular labeling, we were able to reveal structural details in archived retinal samples that were previously very hard to access.”

Unlocking the Potential of Archival Retinal Tissue

Because the method works in extended-formaldehyde-fixed, frozen archival tissue, it could be especially valuable for translational research. Many clinically relevant retinal samples, including human donor tissue and tissue from large-animal disease models, are stored in this form but have been difficult to analyze in molecular detail with fluorescence-based methods. By making those samples more accessible to high-resolution structural study, U-ExM could help researchers better understand how retinal circuits are altered in degeneration, respond to gene therapy, or rebuild after cell transplantation.

“This gives us a practical framework for studying how photoreceptor synapses are built, how they change in disease, and how they may recover after treatment,” said William Beltran, the Corinne R. and Henry Bower Professor of Ophthalmology and senior author of the paper. “That is exciting not only for basic neuroscience, but also for translational efforts aimed at preserving or restoring vision.”

Kei Takahashi is a postdoctoral fellow in the Beltran lab.

Other authors are Natalia Dolgova, research specialist; Raghavi Sudharsan, research assistant professor of Experimental Ophthalmology; and William Beltran, Corinne R. and Henry Bower Professor of Ophthalmology in the Department of Clinical Sciences and Advanced Medicine at Penn Vet, and director of the Division of Experimental Retinal Therapies.

The work was supported by the National Institutes of Health and the International Retinal Research Foundation.

This news release was drafted with the assistance of ChatGPT Plus Thinking 5.4, an advanced AI language model, modified and approved by the study’s authors.